Research from Icahn School of Medicine at Mount Sinai Provides New Data on Thrombocytopenia (Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis)

Press/Media

Period14 Dec 2023

Media coverage

1

Media coverage

  • TitleResearch from Icahn School of Medicine at Mount Sinai Provides New Data on Thrombocytopenia (Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis)
    Media name/outletDisease Prevention Daily
    Country/TerritoryUnited States
    Date14/12/23
    PersonsAndrew Srisuwananukorn, Douglas Tremblay, John Mascarenhas